Engrailed-2 (EN2) is a homeodomain-containing transcription factor that has roles in boundary formation and neural guidance in early development, but which is also expressed in a range of cancers. In addition to transcriptional regulation, it is secreted by cells and taken up by others through a mechanism that is yet to be fully elucidated. In this study, the distribution of EN2 protein in cells was evaluated using immunofluorescence with a set of antibodies raised against overlapping epitopes across the protein, and through the use of an EN2-GFP construct. MX2 expression in primary prostate tumors was evaluated using immunohistochemistry. We showed that EN2 protein is present in the cell membrane and within microvesicles that can be secret...
Background: Epithelial ovarian cancer is a common malignancy, with no clinically approved diagnostic...
BACKGROUND: In prostate adenocarcinoma, the dissection of the expression behaviour of the eukaryotic...
Controversy surrounds the use of PSA as a biomarker for prostate cancer detection, leaving an unmet ...
YesEngrailed-2 (EN2) is a homeodomain-containing transcription factor that has roles in boundary for...
Engrailed-2 (EN2) is a transcription factor involved in development, where it has multiple functions...
Engrailed variant-2 (EN2) has been suggested as a potential diagnostic biomarker; however, its prese...
Epithelial ovarian cancer (EOC) is a common malignancy, usually diagnosed at an advanced stage, resu...
We reported the expression of the homeodomain-containing transcription factor Engrailed-2 (EN2) in p...
Engrailed variant-2 (EN2) has been suggested as a potential diagnostic biomarker; however, its prese...
Background: Ovarian cancer remains the most lethal gynaecologic tumour in the Western world. Stimula...
Background: Prostate cancer is a leading cause of cancer related death in men but its diagnosis is s...
Epstein-Barr virus (EBV) is a gammaherpesvirus associated with numerous cancers, including the epith...
Despite extensive efforts to identify a clinically useful diagnostic biomarker in prostate cancer, n...
Abstract Background Epithelial ovarian cancer is a common malignancy, with no clinically approved di...
What's known on the subject? and What does the study add? There are a lot of potential prostate canc...
Background: Epithelial ovarian cancer is a common malignancy, with no clinically approved diagnostic...
BACKGROUND: In prostate adenocarcinoma, the dissection of the expression behaviour of the eukaryotic...
Controversy surrounds the use of PSA as a biomarker for prostate cancer detection, leaving an unmet ...
YesEngrailed-2 (EN2) is a homeodomain-containing transcription factor that has roles in boundary for...
Engrailed-2 (EN2) is a transcription factor involved in development, where it has multiple functions...
Engrailed variant-2 (EN2) has been suggested as a potential diagnostic biomarker; however, its prese...
Epithelial ovarian cancer (EOC) is a common malignancy, usually diagnosed at an advanced stage, resu...
We reported the expression of the homeodomain-containing transcription factor Engrailed-2 (EN2) in p...
Engrailed variant-2 (EN2) has been suggested as a potential diagnostic biomarker; however, its prese...
Background: Ovarian cancer remains the most lethal gynaecologic tumour in the Western world. Stimula...
Background: Prostate cancer is a leading cause of cancer related death in men but its diagnosis is s...
Epstein-Barr virus (EBV) is a gammaherpesvirus associated with numerous cancers, including the epith...
Despite extensive efforts to identify a clinically useful diagnostic biomarker in prostate cancer, n...
Abstract Background Epithelial ovarian cancer is a common malignancy, with no clinically approved di...
What's known on the subject? and What does the study add? There are a lot of potential prostate canc...
Background: Epithelial ovarian cancer is a common malignancy, with no clinically approved diagnostic...
BACKGROUND: In prostate adenocarcinoma, the dissection of the expression behaviour of the eukaryotic...
Controversy surrounds the use of PSA as a biomarker for prostate cancer detection, leaving an unmet ...